Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911192 | 12591119 | 2 | F | 20160309 | 20160310 | 20160726 | 20160727 | PER | US-UNITED THERAPEUTICS-UNT-2016-004074 | UNITED THERAPEUTICS | 48.00 | YR | F | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911192 | 12591119 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.0402 ?G/KG, CONTINUING | 926618 | 21272 | .04 | UG/KG | INJECTION | ||||||
| 125911192 | 12591119 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1500227A | 0 | 10 | MG | TABLET | QD | |||||
| 125911192 | 12591119 | 3 | C | ADCIRCA | TADALAFIL | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 4 | C | XARELTO | RIVAROXABAN | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 5 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 6 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 7 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 125911192 | 12591119 | 8 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 9 | C | LASIX | FUROSEMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 10 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 12 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | U | U | 0 | |||||||||
| 125911192 | 12591119 | 13 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125911192 | 12591119 | 1 | Pulmonary hypertension |
| 125911192 | 12591119 | 2 | Pulmonary arterial hypertension |
| 125911192 | 12591119 | 3 | Product used for unknown indication |
| 125911192 | 12591119 | 4 | Product used for unknown indication |
| 125911192 | 12591119 | 5 | Product used for unknown indication |
| 125911192 | 12591119 | 6 | Product used for unknown indication |
| 125911192 | 12591119 | 7 | Product used for unknown indication |
| 125911192 | 12591119 | 8 | Product used for unknown indication |
| 125911192 | 12591119 | 9 | Product used for unknown indication |
| 125911192 | 12591119 | 10 | Product used for unknown indication |
| 125911192 | 12591119 | 11 | Product used for unknown indication |
| 125911192 | 12591119 | 12 | Product used for unknown indication |
| 125911192 | 12591119 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125911192 | 12591119 | Device issue | |
| 125911192 | 12591119 | Dyspnoea | |
| 125911192 | 12591119 | Flushing | |
| 125911192 | 12591119 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125911192 | 12591119 | 1 | 20140227 | 0 | ||
| 125911192 | 12591119 | 2 | 20140218 | 0 |